WallStreetZenWallStreetZen

NASDAQ: CLGN
Collplant Biotechnologies Ltd Earnings & Revenue

Buy CLGN
OverviewForecastEarnings
DividendOwnership

CLGN past revenue growth

How has CLGN's revenue growth performed historically?
Company
-93.97%
Industry
1,307.39%
Market
157.87%
CLGN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CLGN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

CLGN earnings and revenue history

Current Revenue
$1.2M
Current Earnings
-$13.7M
Current Profit Margin
-1,138.9%

CLGN Return on Equity

Current Company
-29.5%
Current Industry
6.9%
Current Market
38.4%
CLGN's Return on Equity (-29.5%)... subscribe to Premium to read more.
High Return on Equity Performance

CLGN Return on Assets

Current Company
-26.4%
Current Industry
5.1%
CLGN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

CLGN Return on Capital Employed

Current Company
-30.23%
Current Industry
-16.5%
CLGN has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CLGN vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
CLGN$1.21M-$13.10M-$13.75M+18.22%N/A
BCTX$0.00-$11.27M-$11.20MN/AN/A
GNPX$0.00-$19.98M-$20.01MN/AN/A
RZLT$0.00-$36.11M-$38.13MN/AN/A
DBTX$0.00-$56.21M-$60.36MN/AN/A
View Top Biotech Stocks

Collplant Biotechnologies Earnings & Revenue FAQ

What were CLGN's earnings last quarter?

On Invalid Date, Collplant Biotechnologies (NASDAQ: CLGN) reported Q1 2022 earnings per share (EPS) of -$0.36, up 130% year over year. Total Collplant Biotechnologies earnings for the quarter were -$3.86 million. In the same quarter last year, Collplant Biotechnologies's earnings per share (EPS) was $1.20.

If you're new to stock investing, here's how to buy Collplant Biotechnologies stock.

What was CLGN's earnings growth in the past year?

As of Q3 2022, Collplant Biotechnologies's earnings has grown year over year. Collplant Biotechnologies's earnings in the past year totalled -$13.75 million.

What was CLGN's revenue last quarter?

On Invalid Date, Collplant Biotechnologies (NASDAQ: CLGN) reported Q1 2022 revenue of $66.00 thousand up 99.54% year over year. In the same quarter last year, Collplant Biotechnologies's revenue was $14.50 million.

What was CLGN's revenue growth in the past year?

As of Q3 2022, Collplant Biotechnologies's revenue has grown -93.97% year over year. This is 1,401.36 percentage points lower than the US Biotechnology industry revenue growth rate of 1,307.39%. Collplant Biotechnologies's revenue in the past year totalled $1.21 million.
©2022 WallStreetZen
Company
AboutBlogPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContact
Stocks
Stock ScreenerStock ForecastHighest Earnings StocksBest Dividend Paying StocksStatisticsTrending StocksStock Market SectorsStock Market Industries
Analysts
Top Performing Analysts
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.